EUVIMEDEUVIMED entdecken
Crossref

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Danielle Roman, PharmD, BCOP, Kaitlyn Reeder, PA-C

Journal of the Advanced Practitioner in Oncology · 27.02.2026 · 17 (2)

DOI: 10.6004/jadpro.2026.17.2.8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Advanced Practitioner in Oncology, online erschienen am 27.02.2026. Verfasst von Danielle Roman und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of metastatic hormone receptor–positive (HR+) and human epidermal growth factor receptor 2–positive (HER2+) breast cancer continues to evolve with the development of novel targeted therapies. At JADPRO Live, presenters discussed therapies for this subtype of breast cancer, adverse events, management strategies, as well as biomarkers to consider when making treatment decisions.

Zitieren

APA

Roman, D., PharmD, BCOP, Reeder, K., & PA-C (2026). Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer. Journal of the Advanced Practitioner in Oncology, 17(2). https://doi.org/10.6004/jadpro.2026.17.2.8

Vancouver

Roman D, PharmD, BCOP, Reeder K, PA-C. Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer. Journal of the Advanced Practitioner in Oncology. 2026;17(2). doi:10.6004/jadpro.2026.17.2.8

BibTeX
@article{Roman2026,
  author = {Roman, Danielle and PharmD and BCOP and Reeder, Kaitlyn and PA-C},
  title = {Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer},
  journal = {Journal of the Advanced Practitioner in Oncology},
  year = {2026},
  volume = {17},
  number = {2},
  doi = {10.6004/jadpro.2026.17.2.8}
}
Kostenlos starten →